Boeing, J&J, dismal China data drag Wall Street lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
UPS (UPS) Announces Retirement of COO Jim Barber
October 22, 2019 7:11 AM EDTUPS (NYSE: UPS) today announced Jim Barber, 59, UPS Chief Operating Officer will retire at the end of December 2019. As UPS COO, Barber is responsible for the companys global small package, freight, supply chain and freight forwarding units and global engineering. Serving UPS for nearly 35 years, he joined the company as... More
Actelion Pharmaceuticals Reports New OPSUMIT (macitentan) Data Show Initial Combination Therapy with Tadalafil Improved Hemodynamic Clinical & Functional Parameters in Patients with PAH
October 21, 2019 9:04 AM EDTActelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson (NYSE: JNJ), today announces new data evaluating initial combination therapy with OPSUMIT® (macitentan) and tadalafIl, a PDE5 inhibitor. Patients with pulmonary arterial hypertension (PAH, WHO Group 1) taking this combination showed hemodynamic improvement, as well as improvements in functional parameters and risk profiles. The combination was also well tolerated in these patients. The study data is being shared today at the CHEST Annual Meeting 2019, held October 19-23 in New Orleans, Louisiana.
The OPTIMA (cOmbination theraPy of maciTentan and tadalafIl in patients with... More
Stifel Reiterates Buy Rating on Amazon.com (AMZN) Ahead of 3Q Report
October 21, 2019 8:31 AM EDTStifel analyst Scott Devitt reiterated a Buy rating and $2,300.00 price target on Amazon.com (NASDAQ: AMZN) ahead of the company's 3Q report. Stifel's revenue estimate is modestly ahead of consensus while operating income estimate is below consensus expectations. Amazon is scheduled to report 3Q:19... More
Wells Fargo Reiterates Outperform Rating on American Express (AXP) Following 3Q Report
October 21, 2019 7:06 AM EDTWells Fargo analyst Donald Fandetti reiterated an Outperform rating and $140.00 price target on American Express (NYSE: AXP) following the company's 3Q report. AXP reported EPS of $2.08, higher than the consensus of $2.03. Revenues of $10.989B were higher than $10.943B estimates as NII and other... More
